RE: Another bites the dust8 Feb 2021 10:00
Graking, it's looking a bit shady isn't it? As you say they messed up the dosage to get the vaunted 90% efficacy figure, but then on review the data was not reliable enough for that dosage regimen to be approved, they also averaged this unreliable data with the 62% to get the 70%+ efficacy.
They also seem to have an aversion to testing older people, these preliminary South African results look shockingly bad, at least the Johnson and Johnson vaccine which is about as effective as Astrazeneca otherwise and 57% effective on the SA variant is a single dose vaccine.